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Polymeric nanoparticles have been regarded by many as an attractive class of drug 
delivery system. Oral administration has always been the preferred route of 
administration of therapeutic agents and majority of the available evidence in 
literature suggest that the uptake of orally administered particulates occurs 
predominantly in the intestinal lymphatic tissues. The uptake of particulates into 
cells involved mainly endocytotic processes, which depend primarily on the size 
and surface properties of the particles. The objective of this work is to investigate 
the influence of the physico-chemical properties of polymeric nanoparticles on 
their interactions with cells. Emphasis is placed on the effect of particle size and 
surfactants on (1) inter-particle forces and (2) the interaction of the particles with a 
cell membrane model. The study was carried out on the Langmuir film balance in 
order to first obtain a basic, fundamental understanding on the subject prior to 
further in-depth investigations. It was found that strength of repulsive inter-
particle forces increased with particle size, and the degree of repulsion exerted by 
these forces varied when the particles were coated with different surfactants. The 
biological cell membrane was modelled by a lipid monolayer spread at the air-
water interface. The interacting behaviour of the particles with the lipid monolayer 
was distinctly different for particles of different sizes, as well as those with 
different coatings. Finally, it was observed that the different compressed states of 





                                                                                                                   v   
List of Figures 
 Page 
 
Figure 2.1 Drug Levels in blood with a) traditional dosing b) controlled-delivery 
dosing 7 
 
Figure 2.2 Surface-modified nanoparticle as targeted drug delivery system 8 
 
Figure 2.3 Schematic showing the difference between nanosphere and 
nanocapsule 11 
 
Figure 2.4 Stages involved in the development of polymeric nanoparticles as drug 
delivery systems 12 
 
Figure 2.5 Schematic showing the function of stabilizers 20 
 
Figure 2.6 Structure of PVA 21 
 
Figure 2.7 Structure of Vitamin E TPGS 22 
 
Figure 2.8 Various routes of drug administration 23 
 
Figure 2.9 Pathway of ingested food materials 24 
 
Figure 2.10 Schematic of a cell membrane and its components 28 
 
Figure 2.11 Schematic showing phagocytosis, pinocytosis and receptor-mediated 
endocytosis 32 
 
Figure 2.12 Schematic of a Langmuir trough and typical Π-A isotherm 33 
 
Figure 2.13 Schematic showing penetration of molecules into the lipid monolayer
 34 
 
Figure 2.14 Diagrammatic representation of DSC 36 
 
                                                                                                                   vi   
Figure 2.15  Flowchart showing how FTIR works 37 
 
Figure 2.16  Schematic showing parts of AFM 38 
 
Figure 2.17  Working principle of SPR 39 
 
Figure 3.1 (a) Uncoated 200nm polystyrene particles (b) PVA-coated 200nm 
polystyrene particles (c) TPGS-coated 200nm polystyrene particles 41 
 
Figure 3.2 Set-up of Langmuir film balance/trough used 42 
 
Figure 4.1 Π-A isotherms for monolayers composed of polystyrene particles of 
diameters 200, 500 and 800nm. 45 
 
Figure 4.2 Force vs. Spacing between particle centers curves showing the force 
between 2 adjacent particles a) 200nm b) 500nm and 800nm 48 
 
Figure 4.3 α values for 200, 500 and 800nm particles calculated from their Π-A 
isotherms 50 
 
Figure 4.4 Final increase in surface pressure caused by 200, 500 and 800nm 
particles at different injected volumes. 52 
 
Figure 4.5 Penetration profiles of 200, 500 and 800nm particles when (a) 10µl (b) 
500µl of suspension is injected. 53 
 
Figure 4.6 Final increase in surface pressure caused by 20 and 200nm particles at 
different injected volumes. 55 
 
Figure 4.7 Penetration profile of 20nm particles at various injected volumes. 56 
 
Figure 4.8 a) Penetration profiles of 500nm particles b) Final increase in surface 
pressure at initial surface pressures from 30mN/m to 35mN/m. 60 
 
Figure 4.9  Π -A isotherm of DPPC at 37°C. 61 
 
                                                                                                                   vii   
Figure 4.10 Final increase in surface pressure at initial surface pressures from 
20mN/m to 30mN/m. 62 
 
Figure 4.11 a) Penetration profiles of 500nm particles b) Final increase in surface 
pressure from 10mN/m to 20mN/m. 64 
 
Figure 4.12 XPS spectra of a) Uncoated PS particles, b) TPGS-coated particles 
and c) PVA-coated particles. 66 
 
Figure 4.13  Π-A isotherms of coated and uncoated particles of size a) 200nm, b) 
500nm and c) 800nm. 68 
 
Figure 4.14 Force vs Spacing between particle centers curves for various particles 
of size a) 200nm, b) 500nm and c) 800nm. 70 
 
Figure 4.15 α values for coated and uncoated 500nm particles as a function of S.
 71 
 
Figure 4.16 Penetration profile of the various particles at initial Π = 25mN/m 73 
 
Figure 4.17 Final increase in surface pressure for the various particles at 
monolayer initial surface pressure 30-33mN/m. 76 
 
Figure 4.18 Final increase in surface pressure for the various particles at 
monolayer initial surface pressure 20-30mN/m. 78 
 
Figure A.1 Surface pressure vs trough area for a) uncoated particles of different 
sizes, b) coated and uncoated 500nm particles.                                              93                  
 











                                                                                                                   viii   
List of Tables 
            Page 
 
Table 2.1 Classification of DDSs based on release mechanism and technology 9 
 
Table 2.2 Principle techniques for the physicochemical characterisation of 
nanoparticles 15 
 
Table 2.3 Potential solutions to problems of oral delivery of poorly absorbed 
molecules using nanoparticles 25 
 
Table 2.4 Events leading from Drug-Membrane Interaction 30 
 
































                                                                                                                   ix   
Notation 
 
α   2-dimensional van der Waals constant 
γ  Surface tension of the colloidal solution 
ω  Wetting contact angle of a particle 
(∆E) Penetration  Energy change in the system for the penetration of particles 
through lipid monolayers 
∆E Change in the total system energy 
γm Surface tension of a monolayer  
γw  Surface tension of water  
A Area occupied by the particles in the monolayer 
A0   Co-area of a particle  
AH  Area occupied by the particles when they are hexagonally close-
packed 
F Force per particle normal to imaginary line on the interface 
k  Boltzmann’s constant 
r Radius of the particles in the monolayer  
S Particle centre-centre separation  
T Temperature of the system 
AFM Atomic force microscopy 
DPPC 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine/ 1,2-
Dipalmitoylphosphotidylcholine 
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FTIR Fourier transform infrared 
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Introduction 
Chapter 1 : Introduction 
 
 
1.1 General Background 
In the realm of drug delivery, efforts have been devoted to meet the criteria of 
ensuring reproducible absorption of bioactive molecules that do not naturally 
penetrate bio-barriers or whose absorption cannot be reproducibly predicted from 
physicochemical properties, and selective localization at specific target sites [1]. 
Nanoparticles have received great attention in the field of drug delivery in recent 
years, as they possess the potential to meet the above-mentioned criteria and they 
have high versatility. Nanoparticles are solid colloidal particles ranging in size 
from 10nm to 1000nm [2] and can be used to deliver a wide variety of drugs, 
regardless of their hydrophilic or hydrophobic nature [3]. The small size of 
nanoparticles greatly facilitated the transport of active agents across biological 
membranes, allows them to as pass through the smallest capillaries in the body 
that are 5-6µm in diameter, and can minimize possible carcinogenic effects or 
irritant reactions at the injection site [3,4]. The use of adjuvants that can cause 
toxic side effects, such as Cremophor EL for the administration of Paclitaxel [5], 
can be avoided when the drugs are encapsulated into the polymeric nanoparticles.  
In addition, with their small size and appropriate surface modifications, 
nanoparticles can bypass the mononuclear phagocyte system to prolong their 
circulation. 
 
The effectiveness of the nanoparticulate drug delivery system can only be realised 
if they are taken into the cells. The uptake of particulates into cells involved 
mainly endocytotic processes, which are energy-dependent and also depend 
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primarily on the size and surface properties of the particles [6]. Many publications 
supported the hypothesis that the uptake is inversely proportional to the size of the 
particles [7]. However, it is believed that there is an optimal colloidal size that 
would trigger the endocytotic events [7]. Therefore, it is important to ensure that 
the synthesized nanoparticles do not aggregate; in other words, there must exist a 
certain degree of repulsion between the particles to prevent their aggregation.  
 
In addition, it has been generally observed that more hydrophobic particles are 
absorbed, while the effect of surface charges is still a subject of much discussion 
[6]. The surface properties of the particles vary with the type of materials present 
on the particles’ surfaces and they can be simply modified by coating the particles 
with suitable materials. Often, traces of stabilizers used in the fabrication process 
are left on the particles’ surfaces, and these remnants contribute to the surface 
properties. Polyvinyl alcohol (PVA) is a common stabilizer used in fabricating 
polymeric nanoparticles. Particles formed using this stabilizer are more uniform 
and smaller in size and can be easily disperse in aqueous medium [8]. However, it 
is found that nanoparticles associated with larger amount of PVA are more 
hydrophilic and have lower cellular uptake [9]. On the other hand, vitamin E 
TPGS is amphipathic and is less hydrophilic than PVA. It is said to have the 
ability to enhance absorption through the intestinal wall [10]. It could also 
function as an effective stabilizer for synthesizing of polymeric nanoparticles [11] 
and has found to be able to inhibit the P-glycoprotein; also known as a multi-drug 
efflux pump that reduces the bioavailability of several drugs [12]. Although there 
is yet any reports on the cellular uptake related to TPGS associated particles, its 
amphipathic properties would offer superiority over PVA.  
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One of the most common methods used to study of the influence of the particle 
characteristics in a systematic manner is cell cultures. Cell cultures offer the 
possibility of using pharmacological tools to obtain precise information on the 
mechanisms of uptake [13]. In addition, the close study of the interaction between 
the cells and the particles is also made possible [13].  The number of particles 
taken up by the cells quantifies the extent of interaction, however, there are 
various difficulties involved in the quantitative analysis. For example, direct 
counting with a hemocytometer for particles smaller than 1 micron involves large 
errors and risk of counting the same particle several times, and the use of 
fluorometry do not discriminate whether the particles are inside the tissue or 
merely adsorbed at the cell surface [14].  
 
Although cell cultures are realistic representations of the biological systems, there 
is still a need for other simple, yet reliable method to evaluate the feasibility of the 
nanoparticulate delivery system prior to extensive in-vitro and in-vivo to reduce 
unnecessary waste of time and resources. The Langmuir film balance/trough 
presents great potential in this application. A lipid monolayer spread at the air-
water interface on the trough is the simplest form of membrane model. It reduces 
the complexities of biological membranes, hence allows the investigation of the 
specific aspects of any biological phenomenon occurring in the membranes [15]. 
The advantage of this system is that the nature, packing and type of lipids, as well 
as the composition and temperature of the subphase can be controlled [15]. The 
penetration effect of the substances such as proteins, drugs or surfactants present 
in the subphase into the lipid monolayer can be correlated to their interaction with 
biomembranes. [16]. The influence of the physicochemical properties of 
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nanoparticles on their interaction with cells can also be investigated via 
penetration studies, which are simpler and more specific compared to cell cultures. 
Such studies have been reported but unfortunately they were not very in-depth 
studies [17,18]. Lastly but most importantly, the penetration of materials into the 
lipid monolayers at certain surface pressures was found to be analogous to that 
occurring in lipid bilayers, thereby indicating that the results obtained from 




The main objective of this project is to study the influence of the physicochemical 
properties of polymeric nanoparticles on their interaction with cells. 
 
The focus of the work can be broadly classified as: 
1. The effect of particle size 
2. The effect of surfactant coatings (polyvinyl alcohol and Vitamin E TPGS) 
on the following factors: 
a) Inter-particle forces 
This provides information on the ease of aggregation of the particles, as 
well as the stabilizing properties of various stabilizers. Hence, the 
information obtained can be applied in choosing a suitable stabilizer for 
the fabrication of nanoparticulate drug delivery systems.  
b) Interaction with lipid monolayer 
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The transport of particles into cells occurs mainly via endocytotic 
processes, which are initiated by the interaction between the particles and 
the cell membrane.  
Hence, the lipid monolayer is employed as a cell membrane model to study 
its interaction with polymeric nanoparticles as a means to predict the 
possibility of cell uptake of the particles.  
 
The work is carried out using the Langmuir film balance/trough. The advantage of 
using this instrument is that it is simple to operate, give fast, direct and 
fundamental results.  
 
1.3 Thesis Organization 
The body of this thesis is made up of five chapters. Chapter one gives a brief 
introduction to the project. It comprises of the general background, as well as the 
objective of the project. Chapter two is a collection of summarized information on 
drug delivery systems, polymeric nanoparticles and interaction with cells from 
various literature references. In chapter three, the various materials and methods 
used in the experiments are recorded. The experimental results and discussions are 
presented in chapter four. Finally, the conclusions drawn from the project are 
presented in chapter five. 
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Chapter 2 : Literature Review 
 
 
2.1 Drug Delivery Systems  
Drug delivery systems are technologies that aid or enable the administration of 
therapeutic compounds [20]. Improving efficacy and bioavailability with reduced 
dosing frequency to minimize side effects of a drug can be achieved by 
incorporating the drug into drug delivery systems [21]. In order to achieve 
maximum efficacy and patient compliance, these systems must achieve the 
following [1]: 
1. Suitable pharmacokinetic/pharmacodynamic profiles 
2. An acceptable route of administration in consideration of the anticipated 
dose, dosing frequency and chronicity of the disease 
3. Access to, and retention of, the pharmacological agent at the site of action 
4. Exclusion of the compound from non-target organ, tissue and cells as well 
as defining the potential for adverse effects due to the interaction of the 
drug with non-target tissues. 
 
Drug delivery devices can be broadly classified into 2 main groups: controlled 
release systems and targeted systems [22]. 
 
Controlled Release Systems 
The objective in the design of a controlled drug release system is to release a 
pharmacologically active agent in a predetermined, predictable and reproducible 
fashion [22]. Controlled release systems can provide a more effective drug 
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regimen by keeping the drug concentration in the blood at a constant optimal level 
[22]. Other advantages include the need for fewer administrations, optimal use of 
the drug in question, and increased patient compliance [23]. 
 
 
Figure 2.1 Drug Levels in blood with a) traditional dosing b) controlled-delivery dosing 
(Source: Reference 23) 
 
Targeted Drug Delivery Systems 
The inability of drugs to reach the targeted site of action is often the main factor 
affecting their efficiency. This can be overcome by employing targeted drug 
delivery systems. Targeted drug delivery systems release medications at or near 
the site of action [22]. An advantage of such systems is that high local 
                                                                                                                   7   
Literature Review 
 
concentrations of the drug can be achieved as the drug is delivered predominantly 
to the site of action instead of distributed throughout the whole body.  
 
Figure 2.2 Surface-modified nanoparticle as targeted drug delivery system 
(Source: http://www.targesome.com/tech.html) 
 
2.1.1 Advances in drug delivery 
Drug delivery has advanced from conventional pills to sustained/controlled release 
and sophisticated programmable delivery systems. It has also become more 
specific from systemic to organ and cellular targeting [24]. 
 
Novel drug delivery systems have evolved over a period of time to improve 
patient compliance and optimize the dosage regimen without compromising the 
therapeutic efficacy [24]. Since the introduction of the first sustained-release 
capsule of Dexedrine, several concepts have emerged, including prolonged, time 
and extended release and finally to controlled release [24]. Table 2.1 is a more 
detailed classification of drug delivery systems based on their sophistication and 
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Table 2.1 Classification of DDSs based on release mechanism and technology 





Polymer membrane permeation 





































*CDDS – Controlled Drug Delivery System 
#DDS – Drug Delivery System 
 
The use of microchips as controlled release devices is one of the most recent 
developments. The technology is based on tiny silicon or polymeric microchips 
containing up to hundreds or thousands of micro-reservoirs, each of which can be 
filled with any combination of drugs, reagents, or other chemicals [25]. Complex 
chemical release patterns can be achieved by opening the micro-reservoirs on 
demand using pre-programmed microprocessors, remote control, or biosensors 
[25]. Potential advantages of these microchips include small size, low power 
consumption, absence of moving parts, and the ability to store and release 
multiple drugs or chemicals from a single device [25]. 
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2.1.1.1 Application of delivery strategies in other fields 
Novel delivery strategies have been applied to tissue engineering as well as 
diagnostics  [24]. In tissue engineering, controlled release concepts are used for 
the delivery of growth factors to nurture cells for tissue regeneration [24]. 
Glucowatch TM, a blood glucose-monitoring device, is an example of diagnostic 
application of delivery strategies [24]. The device can extract glucose through the 
skin using reverse iontophoresis coupled to an enzyme-based detection system 
[24]. 
 
2.1.2 Economic Aspect of Drug Delivery Systems 
The process of drug discovery is costly (US$400-650 million), time consuming 
(requiring 10-15 years) and risky [24]. Developing drug delivery systems for an 
existing drug costs substantially less (about 20% of the cost for drug discovery) 
and requires about half of the time [21,24].  The drug delivery industry has been 
growing to provide a wide range of technologies to pharmaceutical companies for 
the reformulation of drugs. According to the investment bank Dillon Read & 
Company, the drug delivery market will grow from 12% of the total 
pharmaceutical market in 1996 to 20% in 2005 [20].  
 
The market value of a reformulated drug arises from the following sources [20]:  
1. Extension of patent life. 
2. Compliance improvement. 
3. Improved therapeutic efficacy. 
4. Reduced manufacturing costs. 
5. Expansion in market share. 
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2.2  Nanoparticles in drug delivery  
Polymeric nanoparticles belong to the group of colloidal drug delivery systems, 
together with microemulsions, liposomes and polymeric micelles etc. They are 
considered better alternatives to liposomes, as they possess better stability [26]. 
Nanoparticles are solid colloidal particles ranging in size from about 10nm to 
1000nm [2]. It is a collective name for nanocapsules and nanospheres. 
Nanocapsules are made up of an oily core (containing the drug) encapsulated by a 
membrane wall while nanospheres have a matrix-like structure in which the drug 
can be dispersed.  
 
Figure 2.3 Schematic showing the difference between nanosphere and nanocapsule 
(Source: Reference 23) 
 
 
Nanoparticles can be used to deliver a wide variety of drugs, regardless of their 
hydrophilic or hydrophobic nature [3]. The small size of nanoparticles greatly 
facilitated the transport of active agents across biological membranes, allows them 
to as pass through the smallest capillaries in the body that are 5-6µm in diameter, 
and can minimize possible carcinogenic effects and irritant reactions at the 
injection site as well [3,4]. The use of adjuvants that can cause toxic side effects 
can be avoided when the drugs are encapsulated into the polymeric nanoparticles.  
In addition, with their small size and appropriate surface modifications, 
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nanoparticles can bypass the mononuclear phagocyte system to prolong their 
circulation. 
 
2.2.1 Stages involved in the development of polymeric nanoparticles 
Figure 2.4 shows the various stages involved in the development of polymeric 
nanoparticles. 
In vivo tests 

































Polymers are the main choice of materials for nanoparticles fabrication due to 
their versatility. The selection of the appropriate polymers requires a 
comprehensive knowledge of the various properties (surface and bulk) of the 
polymer that can give the desired chemical, interfacial, mechanical and biological 
functions, as well as extensive biochemical characterization and specific 
preclinical tests to demonstrate their safety [27]. Surface properties such as 
hydrophilicity, lubricity, smoothness and surface energy not only govern the 
biocompatibility with tissues and blood, but also influence physical properties 
such as durability, permeability, degradability and the water sorption capacity of 
the polymers [27]. Molecular weight, adhesion, solubility based on the release 
mechanism (diffusion- or dissolution-controlled), and site of action of the 
particles, are bulk properties that have to be taken into consideration [27]. Finally, 
one other important concern in the selection of the suitable polymer is its 
compatibility with the drug. 
 
Synthesis of nanoparticles 
 
The preparation of polymeric nanoparticles can be broadly categorized into 2 main 
groups [28]: 
1. In situ polymerization of monomers in various media 
2. Dispersion of a preformed polymers 
The various methods of fabrication will be elaborated in Section 2.2.2. 
As the particles are to be used as pharmaceutical dosage forms in humans, they 
have to be [28] 
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1. Free of potentially toxic impurities 
2. Easy to store and administer 
3. Sterile if they are for parenteral use 
Hence, after preparation, the particles often have to go through purification, 
freeze-drying and sterilization. The commonly reported purification procedures 
are gel filtration, dialysis and ultracentrifugation [28]. For long-term conservation 
of the polymeric nanoparticles, freeze-drying is often employed [28]. It involves 
the freezing of a suspension, followed by the elimination of water by sublimation 
under reduced pressure [28]. As for sterilization, the choice of sterilizing treatment 
depends on the physical susceptibility of the system [28]. 
 
Characterisation of nanoparticles 
Nanoparticles are normally characterized by size, morphology/surface, drug 
content, in-vitro drug release as well as stability [13,28]. The various techniques 
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Table 2.2 Principle techniques for the physicochemical characterisation of nanoparticles 
(Source: Reference 28) 
 
Parameter Technique 
Particle size and morphology Transmission electron microscopy 
Scanning (electron, force, tunnelling) 
microscopy 
Freeze-fracture electron microscopy 
Photon correlation spectroscopy 
 
Drug Content 
In-vitro drug release 
 
High performance liquid chromatography 
Molecular weight Gel permeation chromatography 
 
Crystallinity X-ray diffraction 
Differential scanning Calorimetry 
 
Surface charge Zeta potential measurement 
 
Surface hydrophobicity Hydrophobic interaction chromatography 
Contact angle measurement  
Rose Bengal binding 
 
Surface chemical analysis Secondary ion mass spectrometry 
X-ray photoelectron spectroscopy 
Nuclear magnetic resonance 
Fourier transform infrared spectroscopy 
 
Protein adsorption  2-D polyacrylamide  gel electrophoresis  
 
 
In vitro tests- cell culture 
In vitro models are used to study the influence of the particle characteristics in a 
systematic manner and they offer possibility of using pharmacological tools to 
obtain precise information on the mechanisms of uptake [14].  Using cell culture 
enables the close study of the interaction between the cells and the particles, and 
provides the convenience of short incubation time and feasibility of running 
several samples at one time [14]. The correlation between particle size and the rate 
of interaction with cells has been established and agree well with in vivo data, 








In vivo tests 
In vivo tests give essential information about the oral absorption of the particles, 
in particularly the distribution of the particles [14]. It is the only means to 
determine the actual rate of uptake of ingested particles [14]. The pit-fall of these 
studies is that inter-species and inter-animal differences will limit extrapolation of 
the results to other models and thus prevent study comparison [14]. Furthermore, 
it is not possible to separate out the role of different mechanisms such as uptake 
mechanism and cell-particle interaction using in vivo studies. 
 
Clinical trials 
Clinical trials are studies carried out to determine whether new drugs or treatments 
are both safe and effective [29]. They are often carried out in phases namely [29]: 
 
Phase I:  A new drug or treatment will be tested in a small group of people (20-80) 
for the first time to evaluate its safety, determine a safe dosage range, and identify 
side effects.  
Phase II: The drug or treatment studied is given to a larger group of people (100-
300) to see if it is effective and to further evaluate its safety.  
Phase III: The study drug or treatment is given to large groups of people (1,000-
3,000) to confirm its effectiveness and monitor any possible side effects. It will be 
compared to commonly used treatments, and information that will allow the drug 
or treatment to be used safely is collected. 
Phase IV: Post marketing studies are carried out to delineate additional 
information including the drug's risks, benefits, and optimal use.  
 




Once the delivery system has successfully passed Phase I-III clinical trials and is 
approved by the authorities concerned (e.g. U.S Food and Drug Administration), it 
can then be produced at a large scale and marketed as a product. 
 
2.2.2 Nanoparticles preparation methods using preformed polymers   
Nanoparticles can be prepared from preformed polymers and by polymerisation 
reactions of monomers. The materials used to prepare nanoparticles can be 
broadly classified as synthetic polymers and natural macromolecules [30]. 
 
In this section, only the methods that involve synthetic-preformed biodegradable 
polymers will be presented as these methods are more commonly used. Polyesters 
such as poly (lactic acid) (PLA), poly (lactide-co-glycolide) (PLGA) and poly (ε-
caprolactone) are common materials used due to their good histocompatibility, 
biodegradability and non-toxic by products [30]. 
 
The methods for preparing nanoparticles from preformed polymers can be 
classified into four categories [30,31]: 
1. Solvent evaporation 




The four methods are based on the mechanism of polymer precipitation. Polymer 
precipitation is a generic term used to designate the techniques based on the 
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dissolution of the polymer in a particular solvent, followed by its dispersion in a 
continuous external phase, in which the polymer is insoluble [30]. The difference 
between the methods lies in the miscibility of the organic and aqueous phase  [30].  
For instance, the solvent evaporation method is based on the use of solvents that 
have a limited solubility in water and form emulsions when dispersed in water 
[30]. 
 
1.  Solvent Evaporation 
The solvent evaporation method was first used by Gurny et al for the preparation 
of PLA particles based on the patent filed by Vanderoff et al [28]. The method 
involves the dissolution of a preformed polymer in a volatile organic solvent. The 
organic solution is dispersed in an aqueous phase containing a surfactant or 
stabilizer to form an oil-in water (o/w) emulsion. Continuous stirring prevents the 
coalescence of the oil droplets and this can be further improved by sonication or 
microfluidization [28]. The solvent is removed by evaporation under room 
temperature under stirring or in a rotary evaporator under reduced pressure [28]. 
The diffusional motion of the water immiscible solvent into the aqueous phase is 
slow, thus once the limiting concentration for polymer precipitation is reached, 
phase separation would take place from the interface [30]. As a result, a polymer 
particle is formed from each emulsion droplet when the solvent is removed [30]. 
 
2.  Solvent displacement (or nanoprecipitaton) 
This method was proposed and patented by Fessi et al [30]. It involves the use of 
an organic solvent that is completely miscible with the aqueous phase [28]. 
Polymer precipitation is directly induced in an aqueous medium (with or without 
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stabilizer) by progressive addition of the polymer solution under stirring [28]. This 
method allows nanospheres to be obtained without prior emulsification. The 
usefulness of this method is limited to drugs that are highly soluble in polar 
solvents, but only slightly soluble in water to prevent extensive loss of drug during 
solvent diffusion [28].  
 
3.  Salting-out 
Bindschaedler developed the salting-out method in 1988 [30]. This method is 
based on the separation of a water-miscible solvent from aqueous solution via a 
salting out effect. Acetone is generally chosen as the water-miscible solvent due to 
its solubilizing properties and its well-known separation from the aqueous 
solutions by salting-out with electrolytes [30]. The main advantages of this 
method are excellent yields and easy scaling-up of the process [30].  
 
4. Emulsification-diffusion 
This method is a modification of the salting-out method to avoid the use of salts 
[30]. It involves the use of a partially water-soluble solvent, which is previously 
saturated in water to ensure the initial thermodynamic equilibrium of both liquids 
[30]. Polymer is dissolved in the water-saturated solvent and is emulsified in an 
aqueous solution containing a stabilizer. The subsequent addition of water to the 
system causes the solvent to diffuse into the external phase, resulting in the 
formation of the nanoparticles [30]. 
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2.2.3 Role of stabilizers in nanoparticle synthesis 
The synthesis of polymeric nanoparticles often involves the addition of an organic 
polymer solution to an aqueous solution containing a stabilizer. Stabilizing agents 
are often used to maintain the stability of the emulsions. Good stabilizing agents 
are those with amphipathic properties as they can orient themselves at the 
interface between the droplets and the continuous phase i.e. the lipophilic part of 
the molecule in the oil, the hydrophilic portion in the water [32]. This prevents the 
droplet from coalescing with other droplets [32], which is crucial in particle 
synthesis as it determines the particle size. Furthermore, stabilizers tend to attract 
water molecules and decrease their activity in the aqueous phase.  As a result, 
interfacial tension between the dispersed oil droplet and the water phase is 
lowered and this leads to increased emulsion stability [33]. 
 
 




2.2.3.1 Polyvinyl alcohol (PVA) 
Polyvinyl alcohol (PVA), an effective and important industrial stabilizer used 
since the 1930s [34], is usually used in the synthesis of polymeric nanoparticles 
[3]. The preparation of commercially available PVA often involves the partial 
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hydrolysis of polyvinyl acetate, yielding a block copolymer with the structure as 
shown in Figure 2.6 [34]. It has been found that the degree of hydrolyzation of the 
PVA used in the synthesis of poly(DL-lactide-co-glycolide) nanoparticles can 
affect the productivity and physical properties of particles formed [35]. 
Aggregation of the nanoparticles during post preparative steps such as purification 
and freeze-drying is avoided when PVA is used and it can also enhance particle 
yield in the absence of other adjuvants [30]. Other advantages of using PVA 
include formation of smaller particles with more uniform size, and easy dispersion 
in aqueous medium [8]. The oral administration of PVA is found to be harmless 




Figure 2.6 Structure of PVA 
 
2.2.3.2 Vitamin E TPGS 
TPGS is a water-soluble derivative vitamin E manufactured by Eastman Chemical 
Company. It is prepared by the esterification of the acid group of crystalline d-α-
tocopheryl acid succinate by polyethylene glycol 1000. Besides being able to 
improve the oral bioavailability of vitamin E, TPGS has potential application as a 
drug absorption enhancer as it is said to have the ability to enhance absorption 
through the intestinal wall [10,37,38]. Cell line experiments have verified that 
TPGS can inhibit the P-glycoprotein; also known as a multi-drug efflux pump that 
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reduces the bioavailability of several drugs [12]. Due to this unique property, 
TPGS can hence enhance the efficacy of drugs. Mu and Feng had investigated the 
possibility of using d-α-tocopheryl polyethylene glycol 1000 succinate (vitamin E 
TPGS) as a stabilizer for the fabrication of polymeric nanoparticles for paclitaxel 
delivery [11]. They found that the morphology of the particles formed were 
similar to those synthesized using PVA as stabilizer, thereby indicating that TPGS 
could also function as an effective stabilizer for synthesizing of polymeric 
nanoparticles. 
 
Figure 2.7 Structure of Vitamin E TPGS 
 
2.2.3.3 Other stabilizers 
The poloxamers and poloxamines family of non-ionic surfactants are also 
common stabilizers used in nanoparticles fabrication. These surfactants are 
amphiphilic block copolymers of hydrophobic propylene oxide and hydrophilic 
ethylene oxide and have been discovered to have the ability to prolong the 
circulation time of nanoparticles in the blood stream [39]. 
 
Phospholipids, a major component of the biological membranes, have been widely 
used as emulsifiers in animal feeds, confectionary products, cosmetics, and soaps 
etc [40]. In particular, 1,2-dipalmitoylphosphatidylcholine (DPPC) has been 
suggested to able to improve the performance of the produced PLGA 
microspheres in blood flow, as well as reduce phagocytic uptake of the 
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microspheres. Our group has investigated the effects of various emulsifiers on the 
controlled release of paclitaxel from nanospheres of biodegradable polymers, and 
it was found that phospholipids with short and saturated hydrocarbon chains have 
good emulsifying effects [40]. 
 
2.2.4 Delivery routes and oral delivery of polymeric nanoparticles  
A major attraction of nanoparticles is that they can be delivered via several routes 







*IV – Intravenous, IM - Intramuscularly, SC - Subcutaneous, IN – Intranasal 
Figure 2.8 Various routes of drug administration 
Source:(http://www.psynt.iupui.edu/alcohol396/id115.htm) 
 
Oral administration has always been the preferred route of administration of 
therapeutic agents. It is the easiest form for patient to tolerate and has high 
compliance being convenient and uncomplicated (requiring few dosage per day). 
This route of administration has the advantage of quickly and easily placing the 
                                                                                                                   23   
Literature Review 
 
therapeutics in contact with the relatively large surface membrane of the 
gastrointestinal tract, which has a rich supply of capillaries for entry into the 
plasma compartment [41]. The pathway of the ingested therapeutics is analogous 
to that of food materials as shown in Figure 2.9 
 
 





2.2.4.1 Nanoparticles as a solution to problems in oral drug delivery 
The gastrointestinal tract is a complex system, making up of several 
morphological and physiological barriers that can affect the absorption of 
therapeutics into the systemic circulation. The application of nanoparticles as a 
drug delivery system can circumvent some of the problems existing in the oral 
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Table 2.3 Potential solutions to problems of oral delivery of poorly absorbed molecules using 
nanoparticles 
(Source: Reference 7) 
 
Problematic drug and/or nanoparticle 
property 
Potential Solution 
Low Solubility Nano-solubilization using solid lipid 
nanoparticles, dendrimers or co-precipitates 
 





Timed release / bioerosion /mixed batch of 
differently sized nanoparticles 
 
Poor distribution to target tissues 
 
Attachment of ligands, timed release from 
capsules 
 
Low translocation efficiency 
 





Polymer coating with low contact angles 
 




Adsorption to stomach contents / wall 
 
Administration in different vehicles 
 
 
2.2.4.2 Sites of particle uptake 
Majority of the available evidence in literature suggests that the predominant sites 
of particulates uptake/absorption are the intestinal lymphatic tissues (also known 
as the Peyer’s patches) [42].  This supported the belief that the bulk of particulate 
translocation occurs in the follicle-associated epithelium (FAE). Peyer’s patches 
are collections of lymphoid follicles, which are separated from the lumen by the 
FAE [43]. The FAE is a specialized epithelium covering the mucosal lymphoid 
tissue. It contains membraneous microfold (M) cells that are specialized for 
transcytotsis [42, 43] as well as absorptive enterocytes. The uptake of 
macromolecules by the intestinal M cells is well established as a source of 
immunity in the newborn [44]. It is believed that transcytosis across M cells is the 
most efficient pathway for particulate translocation on a per cell basis [43], hence 
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targeting to the M cells is viewed as one of the means to improve oral delivery of 
particulate systems. 
 
2.2.5 Fate of nanoparticles after entering the systemic circulation 
2.2.5.1 Elimination from the circulation by the MPS 
The observation of particles in Peyer’s patches suggests that nanoparticulate 
systems can be transported across the GI tract wall intact after oral administration 
[43]. Since the particles are not endogenous materials, it is possible that they can 
be removed from the circulation by the mononuclear phagocyte system (MPS, 
also known as the reticuloendothelial system, RES) [45].  The MPS is made up of 
tissue-bound white blood cells (macrophages), and is part of the human immune 
system. The principle tissues associated with the MPS are the liver, spleen and the 
bone marrow.  
 
The MPS can be bypassed by using the following methods [45]: 
1. Suppressing the immune system. 
This can allow the particles to remain in the circulation for a prolonged 
period of time, but will lower the patient’s resistance to infection. 
 
2. Prevent opsonization 
Opsonization is the process where the blood components are absorbed to 
the surface of the particle in the blood stream [45]. The components, also 
known as opsonins, are macromolecules that can be flexible or rigid. 
Flexible molecules adhere to the particle by multi-point attachment, 
forming large numbers of weak bonds per molecule. Rigid molecules are 
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believed to undergo structural rearrangement upon adsorption, resulting in 
an increase in the entropy of the system. These two factors render the 
adsorption process effectively irreversible [45]. 
 
After opsonization, the particles are recognized by the MPS and 
phagocytosis into the macrophages occurs. It is possible to prevent 
opsonization by altering the surface characteristics of the particles. The 
recogniti on process may involve the size, surface charge and chemical 
nature of the particle [45]. 
 
2.2.5.2 Extravasation 
Another problem that arises even if the particles can avoid the MPS is the ability 
of the particles to leave the circulation to reach the target organs. Particles cannot 
simply diffuse through capillaries membranes like small molecules. Extravasation 
refers to the escape of the particles from the circulation [45]. 
 
Extravasation is possible in sinusoidal or discontinuous capillaries (the vessels 
that carry out the exchange of oxygen and nutrients in the liver, spleen and bone 
marrow). These contains gaps that are approximately 100nm, passing through 
both the capillary cells and the basement membrane. On the other hand, if 
particles are retained by physical entrapment in the capillary network of an organ, 
followed by slow release, extravasation will not pose as a problem [45]. 
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2.3 Interaction with cells – a therapeutics perspective 
The interaction with cells stem primarily from the interaction with cell 
membranes. The main function of cell membranes is to act as a barrier between 
the cells and their environment. They are selectively permeable, allowing a very 
few molecules across it while fencing the majority of organically produced 
chemicals inside the cell [46]. Cell membranes are often modelled as a lipid 
bilayer embedded with various proteins and carbohyhdrates (see Figure 2.10). 
Membranes pose as a morphological barrier to both the absorption of drug as well 




Figure 2.10 Schematic of a cell membrane and its components 
(Source: http://ntri.tamuk.edu/cell/membranes.html) 
 
2.3.1 Drug-Membrane Interaction 
A drug can only exert its effect when it is able to reach the specific tissue or site of 
action. One of the most important determinants of a drug effect is the 
concentration of the drug molecules in the blood plasma. The drug concentration 
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is determined by the rate of entry into the blood stream and the rate of exit from 
the bloodstream [41]. In each case, the compound must cross a membrane barrier 
[41], indicating the interaction of the drug with biological membrane is of 
significant importance. 
 
Previously, the interest of drug research and Quantitative Structure-Activity 
Relationship has been focussed on the interaction of drug molecules and the 
proteins of specific receptors and the importance of the drug-membrane 
interaction was underrated [47,48]. Recently, there is increasing evidence showing 
that the influence of the drug-membrane interaction has been underestimated 
[47,48].   
 
Drug-membrane interaction could affect: 
1. Drug transport 
This is because drug transport occurs by either passive diffusion through the lipid 
bilayer or through pores [48]. 
2. Drug Distribution and Accumulation 
The distribution and accumulation of drugs in membranes is an outcome of the 
partition behaviour of the drugs in the lipid bilayers, which in turn is affected by 
drug-membrane interaction. 
3. Drug Efficacy 
There is some evidence showing that the drug-membrane interaction is directly 
related to drug efficacy. In a study done on neuroleptics, it was observed that the 
increase in the interaction between the drug and membrane was paralleled by an 
increase in the pharmacological effect [48]. 
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4. Drug Resistance 
Drug resistance could be due to mechanisms such as [48]: 
i. Modifications of the walls of targeted cells 
ii. Overproduction of target enzymes or proteins  
iii. Conformational change in binding sites 
These could result from the changes in the physical and thermodynamic properties 
of the membranes induced by drug-membrane interactions. 
 
The interaction between the drug and membrane affects both the drug molecules 
and the lipid bilayers. The table below lists some of the possible events leading 
from to drug-membrane interaction: 
Table 2.4 Events leading from Drug-Membrane Interaction 
(Source: Reference 47,48) 
 
Drug ↔ Interaction 
 
I. Action of Membrane on Drug Molecules 
• Diffusion through membrane may become rate limiting 
• Membrane may prevent complete diffusion to active site 
• Membrane may bind drug (accumulation) 
• Solvation of drug in membrane may lead to conformational changes in the 
drug molecules 
 
II. Drug Action on Membrane Properties 
• Drug may change conformation of acyl groups (trans-gauche) 
• Drug may increase membrane surface 
• Drug may increase thickness of membrane  
• Drug may change phase transition temperature (fluidity, cooperativity) 
• Drug may change membrane potential and hydration of head groups 
• Drug may change membrane fusion 
 
 
2.3.2 Nanoparticle-membrane interaction 
The major factor that nanoparticle-membrane interaction affects directly is the 
uptake into of the particles into cells as well as their transport across the intestinal 
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epithelium to reach the systemic circulation. These two processes occur mainly 
via transcytosis, which involve endocytotic processes. Endocytotic processes are 
characterized by the pinching of membrane vesicles from the plasma membrane, 
followed by an internalization of the engulfed extracellular materials [6]. These 
processes include phagocytosis, pinocytosis and receptor-mediated endocytosis 
[49].  
 
Phagocytosis is generally used to describe the cellular "ingestion" of large 
particulate matter (particles larger than 500 nm [50]) while pinocytosis and 
receptor-mediated endocytosis are associated with the uptake of smaller materials 
[49]. Pinocytosis is the non-specific uptake of small droplets of extracellular fluid 
by membrane vesicles [50], hence the transcytosis of particulates would involve 
mainly phagocytosis and receptor-mediated endocytosis. 
 
Receptor-mediated endocytosis requires receptors at the apical cell membrane, and 
is an energy and time-dependent process. The process is initiated by specific 
ligand-receptor interactions [6]. Phagocytosis is initiated by an unspecific physical 
adsorption of material to the cell surface by electrostatic forces. Since the 
initiation of these processes requires particulate-membrane interaction, it therefore 
is an important determinant of the fate of the particles.  




Figure 2.11 Schematic showing phagocytosis, pinocytosis and receptor-mediated endocytosis 
(Source: http://cellbio.utmb.edu/cellbio/recend.htm#internalization) 
 
2.3.3 Techniques involved in studying molecular interactions  
There are various techniques that could be employed to study molecular 
interactions; the following presents a few examples: 
1. Langmuir Film Balance/Trough 
2. Nuclear Magnetic Resonance Spectroscopy (NMR Spectroscopy) 
3. Differential Scanning Calorimetry (DSC) 
4. Fourier Transform Infra-Red Spectroscopy (FTIR Spectroscopy) 
5. Atomic Force Microscopy (AFM) 
6. Surface Plasmon Resonance (SPR) 
 
1. Langmuir Film Balance/Trough 
The Langmuir film balance/trough is a simple piece of equipment, making up of a 
rectangular trough and a pair of barriers (see Figure 2.12). The fundamental use of 
the trough is to measure surface pressure (Π), which is defined as  
γγ −=Π o     (2.1) 
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where γo is the surface tension of clean surface and γ is surface tension of 
monolayer surface. Often, the Wilhelmy method is used in Π measurements. In 
this method, a small paper hanging from a microbalance is immersed in water and 
the force by which the paper is pulled into the water is measured [51]. This 
downward force acting on the paper changes with composition of interface as well 
as during the compression of the monolayer surface as it affects surface tension 




∆−=Π   (2.2) 
where ∆F is change in net downward force and w is width of the plate. 
 
The results obtained are often documented as Π-A isotherms. The measured Π can 
be assumed to be a function of the three interfacial forces, namely kinetic, van der 
Waals and electrostatic charge repulsion [52]. The trough provides a fundamental 
and straightforward means to study the interaction between amphiphiles, as well 
as that between a bulk soluble material and an insoluble monolayer. 
 
Figure 2.12 Schematic of a Langmuir trough and typical Π-A isotherm 
(Source: http://staff.aist.go.jp/tabe-yuka/intro-2.html 
               http://www.nima.co.uk/basics/basindex.htm) 
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The lipid monolayer at the air-water interface has been regarded as a simplified 
biomembrane model. The advantage the lipid monolayer system is that the nature 
and type of lipids, as well as the composition and temperature of the subphase can 
be varied [15] The adsorption of various materials such as proteins, drugs and 
surfactants, onto the biomembranes initiates many important biomedical and 
biophysical processes [16]. Penetration studies carried out on the Langmuir trough 
allow one to investigate the interaction between these materials and the biological 
membranes, thereby providing a channel to understand the mechanism of the 
initiation process.  
 
 




2. Nuclear Magnetic Resonance Spectroscopy (NMR Spectroscopy)  
Nuclear magnetic resonance is a phenomenon that occurs when the nuclei of 
certain atoms are immersed in a static magnetic field while at the same time 
exposed to a second oscillating magnetic field [53]. Only nuclei with the property, 
spin, can experience this phenomenon. NMR spectroscopy is used to study the 
physical, chemical and biological properties of matter. 
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In a molecule, the electron density around each nucleus varies according to the 
types of nuclei and bonds in the molecule [53]. Therefore, the effective field at 
each nucleus will vary and this is called the chemical shift phenomenon [53]. The 
detection of molecular interaction can be achieved by observing the variation in 
the chemical shift. 
 
NMR has been frequently used in conjunction with the Langmuir film balance to 
study the interactions of various materials with membrane lipids in order to 
elucidate their interactions with cell membranes. 13C NMR was reported to be 
utilized to study the interaction between melittin, a major component of bee 
venom that is capable of potentiating the activity of soluble and membrane-bound 
phospholipidases A, with chloroplast lipids [54]. In addition, 31PNMR has been 
used to study the interaction between cholesterol and gangliosides, a form of 
membrane lipid that is concentrated on the outer surface of animal plasma cell 
membrane [55]. 
 
3. Differential Scanning Calorimetry (DSC) 
Differential Scanning Calorimetry is a form of thermal analysis technique based 
upon the detection of changes in the heat content (enthalpy) or the specific heat of 
a sample with temperature [56]. It measures various thermal transitions such as 
melting, changing of   one solid directly to another, crystallization, decomposition, 
out-gassing, sublimation or a change in heat capacity [57]. A DSC thermogram 
normally gives the temperature at which these transitions occur. A shift in the 
transition temperature indicates a variation in the structural property of a material, 
which could be due to the interaction with another material. 




Figure 2.14 Diagrammatic representation of DSC  
(Source: Reference 56) 
 
Goldmann et al investigated the possible interaction between fragments of actin 
binding proteins and lipid bilayers using DSC, in order to understand the function 
of these proteins at cellular level [58]. The results obtained were found to 
correspond to analyses based on the Langmuir trough, thereby proving the 
effectiveness of DSC to study interactions with cell membranes. 
 
4. Fourier Transform Infrared Spectroscopy (FTIR Spectroscopy) 
Fourier transform infrared spectroscopy is a powerful tool for the identification of 
the chemical bonds present in a molecule by producing an infrared absorption 
spectrum that is analogous to a molecular "fingerprint” [59]. This is because when 
a beam of infrared radiation is directed through a specimen, specific bonds in the 
molecules of the sample will absorb radiation from the beam at certain frequencies 
or wavelengths, giving rise unique absorption bands [60]. The absorption 
spectrum is a 2-dimensional plot representing the intensity, which is related to the 
concentration of the component, and frequency of the sample absorption [61]. 
 




Figure 2.15  Flowchart showing how FTIR works  
(Source: Reference 62) 
 
FTIR can be employed to study molecular orientation and defects, as well as 
performing chemical analysis as a function of them [63]. It can also provide 
details on the bonds formation or breakage due to materials interacting with 
phospholipids of the cell membranes [64] 
 
5. Atomic Force Microscopy (AFM) 
The atomic force microscope (AFM) is a form of scanning probe microscopes. It 
utilises a sharp probe (a cantilever) moving over the surface of a sample in a raster 
scan [65]. AFM is used not only to image the surface in atomic resolution but also 
measure the force at nano-newton scale [66] as it can sense a rich variety of forces 
[67]. In the non-contact mode (of distances greater than 10Å between the tip and 
the sample surface), van der Waals, electrostatic, magnetic or capillary forces 
produce images of topography, whereas in the contact mode, ionic repulsion 
forces take the leading role [67]. The objective of the AFM operation is to 
measure the forces (at the atomic level) between a sharp probing tip and a sample 
surface [67]. Various images are obtained by scanning the sample relative to the 
probing tip and measuring the deflection of the cantilever as a function of lateral 
position [67]. Recently, more attention is placed on the construction of tips to 
measure specific force interactions in cells. This would allow one to study the 
biophysics of molecular interactions and its role in important processes such as 
signal transduction, the process by which information flows throughout a 
biological system [67]. 




Figure 2.16  Schematic showing par
(Source: Reference 66) 
 
6. Surface Plasmon Resonance (SPR) 
Surface plasmon resonance is an electron charge de
arises at the surface of a metallic film when light 
specific conditions [68]. The resonance is a result of
transformed from incident photons into surface pla
refractive index of the medium on the side of the film
the light is reflected [68]. When molecules in the
surface, the concentration and therefore the refractive
and an SPR response is detected [69]. The respon
sensorgram during the course of an interaction provi
the progress of the interaction [69]. SPR has been 
example drug delivery, ligand fishing, mutatio
transcriptional regulation, immunoassays and vaccine
 
                                                                         ts of AFM 
1. Laser  
2. Mirror  
3. Photodetector  
4. Amplifier  
5. Register  
6. Sample  
7. Probe 
8. Cantilever  
  nsity wave phenomenon that 
is reflected at the film under 
 energy and momentum being 
smons and is sensitive to the 
 opposite to that from which 
 sample bind to the sensor 
 index at the surface changes 
se plotted against time in a 
des a quantitative measure of 
employed in many fields for 
n studies, cell signalling, 
 development [70]. 




Figure 2.17  Working principle of SPR  
(Source: Reference 68) 
 
Supported lipid monolayers can be formed on an alkane-thiol self-assembled 
monolayer that is mounted on a gold surface, making it suitable for SPR analysis. 
This allows the study of various receptor-analyte interactions in a membrane-like 
environment [71].
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Chapter 3 : Materials and Methods 
 
 
3.1  Materials 
Polystyrene particles of size 20nm (21nm±1.5nm), 200nm (199nm±6nm), 500nm 
(499nm±6.5nm) and 800nm (799nm±9nm) were bought from Duke Scientific 
Corporation (California, USA). The particles were certified with calibrated mean 
diameters (calibrated by Transmission Electron Microscopy) traceable to the 
Standard Meter through the National Institute of Standards and Technology 
(NIST). GR grade ethanol from Merck (Darmstadt, Germany) was used as a 
spreading solvent. Polyvinyl alcohol (PVA, MW 30, 000- 70, 000, 87%- 90% 
hydrolysed) and Vitamin E TPGS (MW 1513) were obtained from Sigma (St. 
Louis, USA) Eastman Chemical Company (Tennessee, USA) respectively.1,2-
Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC, > 99%) was purchased from 
Avanti Polar Lipids Inc. (Alabama, USA). All materials were used as received 
without further purification. Ultrapure water used in the experiments was obtained 
from a Milli Q Plus 185 system (Millipore, Massachusetts-USA). 
 
3.2 Methods 
3.2.1 Particle coating 
PVA and TPGS solutions of known concentration were first prepared. Equal 
volumes of the surfactant solution and particle suspension were mixed under 
magnetic stirring. The mixture was left stirring for 24 hours after which it was 
centrifuged. The supernatant was disposed and ultrapure water was added to make 
up to the volume equivalent to that of the original particle suspension used. 
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Figure 3.1 (a) Uncoated 200nm polystyrene particles (b) PVA-coated 200nm polystyrene 
particles (c) TPGS-coated 200nm polystyrene particles 
 
3.2.2 X-ray Photoelectron Spectroscopy (XPS) 
The surface chemistry analysis of the various particles, pure TPGS and pure PVA 
was performed using AXIS His-165 Ultra from Kratos Analytical. The survey 
spectrum of all samples was recorded over a binding energy range of 0-1200eV 
using a pass energy of 40eV. Curve fitting was carried out using the software 
provided by the manufacturer, and energy scale correction for the C1s region was 
performed by referencing the C-C/C-H peak at 285eV. 
 
3.2.3 Π-A isotherms and penetration.  
The Π-A isotherms measurements and penetration experiments were carried out 
on a computer-controlled miniature Langmuir film balance (model 601M) 
manufactured by Nima Technology (Coventry, U.K.). The equipment consisted of 
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a 100cm2 trough fitted with 2 mechanically coupled barriers and a detachable 
surface pressure sensor. The operating software provided by the manufacturer 
allowed the input of various parameters, such as the compression speed of the 
barriers and the surface pressure that the monolayer was to be compressed to. 
Changes in the surface pressure detected by the pressure sensor during the course 
of the experiment were immediately translated to data points on an Π-A grid of 
the operating software via the computer interface unit, thereby allowing on-line 
observation. The balance was made of Teflon® and had built-in water channels to 
control the temperature of the subphase. It was housed in a rectangular glass 
chamber with a door and anti-motion stands. The chamber was closed during the 
experiments to prevent interference from the surroundings. Prior to the start of an 
experiment, the chamber was left opened to allow the internal and external 










Figure 3.2 Set-up of Langmuir film balance/trough used 
 
Π-A isotherms measurements  
The film balance was first wiped with chloroform-soaked cotton buds and rinsed 
with ultrapure water. Before the particles were spread, cleanliness was checked by 
ensuring that the surface pressure fluctuations did not exceed ± 0.2mN when the 
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barriers were closed to the minimal area. Subsequently, the balance was rinsed 3 
times with ultrapure water before every run. In all the experiments, 120cm3 of 
ultrapure water was added to the balance and temperature was kept constant at 
25°C with an external circulator. The particles were spread with a Hamilton 
microsyringe and 5 min was allowed for the solvent evaporation before the 
experiment was started. The monolayers were compressed at the rate of 8cm2/min.  
The particle suspensions were prepared by diluting the original suspensions from 
the supplier (or the prepared coated particles) with ultrapure water and ethanol 
(which made up 20% of the final suspensions). The amount spread was carefully 
calculated such that the total area occupied by the particles was 5.75% of the 
entire surface of the balance. 
 
Particle penetration experiments 
 
DPPC solution was spread on the ultrapure water subphase and 5 min was allowed 
for solvent evaporation before the lipid monolayer was compressed to the desired 
surface pressure (ranging from 10m/m to 35mN/m). The particle suspension was 
then slowly injected into the subphase with a Hamilton microsyringe and the 
surface pressure was monitored over a period of time (maximum of one hour). In 
all the experiments, the temperature was kept constant at 37°C with an external 
circulator. The particle suspensions were prepared by diluting the original 
suspensions from the supplier with ultrapure water to a concentration of 
1.25mg/ml. 
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Chapter 4 : Results and Discussions 
 
 
4.1 Effect of Particle Size  
4.1.1 Analysis of the Π-A isotherms of particulate monolayers. 
The Π-A isotherms of three particulate monolayers composed solely of 200, 500 
and 800nm particles respectively are shown in Figure 4.1. These three sizes are 
chosen for our study as polymeric nanoparticles fabricated often fall in this range 
of sizes. 
 
The measured Π can be assumed to be a function of the three interfacial forces, 
namely kinetic, van der Waals and electrostatic charge repulsion [52]. In the 
course of compressing the monolayer, these interfacial forces get more 
pronounced as the distance between the monolayer components decreases, hence 
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Figure 4.1 Π-A isotherms for monolayers composed of polystyrene particles of diameters 200, 
500 and 800nm. 
 
In general, it was observed that the form the isotherms assumed was distinctly 
different for each particle size. The increase in surface pressure for the 800 nm 
particles could be detected at larger area compared to the 200 nm ones. Also, the 
surface pressure generated by large particles was clearly higher than by smaller 
particles. The results obtained were within expectations as Lefebure et al had 
observed this in their study of monodispersed magnetic nanoparticles [72]. They 
noted that the shape of the Π-A isotherms seemed to be dependent on particle size 
and attributed this dependency to inter-particle interactions. Therefore, we could 
postulate that the inter-particle forces between larger particles operate over a 
longer range compared to smaller particles.  
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4.1.2 Inter-particle forces 
Utilizing the isotherm data obtained, we carried out further analysis to estimate the 
strength of the inter-particle forces as well as to examine the nature of these 
forces. 
 
4.1.2.1 Strength of the inter-particle forces 
The strength of the inter-particle forces was evaluated using the method derived 
by Clint and Taylor [73]. They proposed that the measured surface pressure was 
equivalent to the repulsive force occurring between two rows of particles in a 
hexagonal array, per unit length of an imaginary line along the interface [73]. If 
the particle centre-to-centre separation is S, then the number of particles per unit 
length of this line is 1/S. For each of these particles, the only forces with 
components perpendicular to this line would arise from the interactions between 
two particles (on each side) touching it, but not in the line [73]. At equilibrium, 
these forces will be balanced by two similar forces from adjacent particles on the 
other side of the line [73]. Therefore the force per particle normal to the line is 
given by 
2F cos 30° = F (3) 1/2  (4.1) 
 Π,  which is equal to the force per unit length of the imaginary line is: 
Π =  F(3) 1/2/S                       (4.2) 
Hence, F can be evaluated from the –A isotherms using the following relation:  
F = Π S/(3) 1/2                 (4.3) 
where S is the particle centre-centre separation given by: 
S = 2r (A/AH) 1/2                    (4.4) 
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r is the radius of the particles in the monolayer and AH represents the area 
occupied by the particles when they are hexagonally close-packed. AH is evaluated 
following the definition [74]: 
AH = 3.148/r           (4.5) 
The dimensions of all the parameters in Eq. 4.1- 4.5 are in S.I units (kg-m-s). 
  
The method is based on the assumption that the inter-particle forces are repulsive. 
It must be noted that the method will not be valid if the particles are forced into 
the subphase i.e. beyond the area where they assume hexagonal close packing 
[72]. Since our experimental conditions met the requirements, we applied the 
method to interpret our data. 
 
Our calculations (presented in Figure 4.2) show that the strength of the inter-
particle forces increases with particle size. This agrees with the size dependency 
of the attractive and repulsive forces found between 2 spheres. Furthermore, 
interaction energies between spheres at fluid interfaces have already been found to 
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Figure 4.2 Force vs. Spacing between particle centers curves showing the force between 2 
adjacent particles a) 200nm b) 500nm and 800nm 
 
4.1.2.2 Nature of the inter-particle forces 
Between the particles, an array of forces such as van der Waals, electrostatic as 
well as capillary forces, is operative. Therefore, there exists a certain degree of 
difficulty to distinguish which of the forces is dominant. To investigate the net 
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overall effect of these forces, we employed a simple approach to using the van der 
Waals equation of state for surface monolayers: 
(Π + α/A2)(A-A0) = kT   (4.6) 
where α is the 2-dimensional van der Waals constant, A0  is the co-area of a 
particle (taken as πr2), k is the Boltzmann’s constant and T is temperature of the 
system in Kelvin. Π and A are obtained from the Π-A isotherms. With the surface 
pressure data obtained, we could evaluate α from Eq. 4.6. The function of α in the 
equation is to account for lateral interactions in the monolayer. Positive α values 
indicate attraction while negative values show the presence of repulsive forces 
[76]. 
 
The α values obtained for the 200, 500 and 800nm are negative (see Figure 4.3), 
implying that the particles experience repulsion within the monolayer. This also 
justify that it is appropriate to use the Clint and Taylor method as its assumption is 
valid.  
 
For all the three sizes, inter-particle repulsion grew stronger as the particles got 
closer but weakened after it reached a maximum. This variation in the inter-
particle forces, with respect to the distance between the particles within the 
monolayer, also exists in a suspension [77]. It was also observed that the 
magnitude of α increased with particle size in accordance with the strength of the 
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Figure 4.3 α values for 200, 500 and 800nm particles calculated from their Π-A isotherms 
 
4.1.3 Penetration Analysis 
 Monolayer penetration describes the interaction of an insoluble monolayer spread 
at the air-water interface with a soluble material in the aqueous phase [15]. 
Penetration behaviour of molecular species, in particularly proteins, has been 
extensively studied. A diffusion-penetration-rearrangement model has been 
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established for protein penetration to a clean air-water interface, which states that 
the process involve the diffusion of protein molecules to the interface to form a 
monolayer, followed by insertion of additional molecules and rearrangement of 
those adsorbed at the interface [78]. In the presence of a lipid monolayer, the 
penetrating molecules insert into the monolayer immediately after diffusing to the 
interface and rearrange themselves, resulting in a shorter time required before an 
apparent surface pressure can be observed [78]. Although the physico-chemical 
properties of polymeric particles are different from proteins, our results obtained 
suggest that particle penetration into the lipid monolayer is similar to the 
diffusion-penetration-rearrangement model. 
 
4.1.3.1 Penetration behaviour of 200, 500 and 800nm particles 
 In general, the increase in surface pressure caused by the penetration of the 
particles increases with the amount of particles injected into the subphase (see 
Figure 4.4). When small amounts of particles were injected, it appeared that the 
particles must be sufficiently large enough in order to cause an observable change 
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Figure 4.4 Final increase in surface pressure caused by 200, 500 and 800nm particles at 
different injected volumes. 
 
For all the three sizes, the rise in surface pressure seemed to smooth off after a 
prolonged period of time and was especially apparent at high injected 
concentrations (Figure 4.5). To explain this, we can regard the particle penetration 
process as being analogous to the adsorption of molecules to a surface. In the 
beginning, there are plenty for available sites present for the penetrating species. 
But as these sites dwindle with time, ultimately saturation will be reached where 
no more penetration can occur. Alternatively, it could also be due to the complete 
penetration of all the particles from the subphase 
 
The diffusion of the particles to the surface does in some way contribute to the rise 
in surface pressure. This is particularly evident at short time periods after the 
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injection was completed (less than 500s), where it is observed that the surface 
pressure increment caused by the smaller particles is slightly higher (Figure 4.5). 
This can be credited to their higher diffusivity, which gives them the ability to 









































































Figure 4.5 Penetration profiles of 200, 500 and 800nm particles when (a) 10µl (b) 500µl of 
suspension is injected. 
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One contradictory trait noted was that at the end of the experiments, the largest 
particle size gave the highest increment in surface pressure (especially at high 
injected volumes). This brings to our notice that the diffusivity of the particles 
could only be a minor factor contributing to the increase in surface pressure. 
Surface pressure will increase with the insertion of molecular species into the 
monolayer under constant area conditions and this increment is attributable to the 
compression of the lipid molecules within the monolayer [19].  As shown 
previously, larger particles at the air-water interface experience greater repulsion 
over a longer inter-particle distance as compared to smaller ones. This inter-
particle repulsion, as well as the greater change in area caused by the larger 
particles during penetration, could significantly compress the lipid monolayer 
thereby giving a considerably larger increase in surface pressure in comparison to 
the penetration of smaller particles. As a result, for particle penetration, we could 
not simply equate the increase in surface pressure to the amount that had 
penetrated. For such systems, we must take into considerations the effect of the 
interactions between the penetrated species at the air-water interface, as well as 
that between the penetrated species and the lipid molecules when analysing the 
penetration profiles. The final outcome is a balance of both issues. 
 
4.1.3.2 Penetration of 20 and 200nm particles 
The isotherm for particles of 0.4nm evaluated using the Volmer equation of state 
Π (A-A0) = kT  (4.7) 
has a shape similar to small amphiphiles like myristic acid [76], hence implying 
that particles in that size range exhibit molecular behaviour. We presume that 
20nm particles should exhibit behaviour close to that of molecules and the 200nm 
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ones represent mesoscopic species (those with sizes between standard particles 
and molecular species) [79]. Using these two sizes allow us to study the difference 
in behaviour of molecular and mesoscopic species and the results are shown in 
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Figure 4.6 Final increase in surface pressure caused by 20 and 200nm particles at different 
injected volumes. 
 
Contrary to what was observed earlier, the increase in surface pressure is higher 
for the 20nm particles than for the 200nm ones at all volumes injected (see Figure 
4.6). This might be due to the rapid diffusion of the smaller particles towards the 
lipid monolayer. Therefore, at any point of time, the amount of penetrated 20nm 
particles could be significantly more than the 200nm particles, causing a greater 
degree of compression on the lipid components of the monolayer and giving rise 
to considerably higher increase in surface pressure. 
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Figure 4.7 Penetration profile of 20nm particles at various injected volumes. 
 
When a large volume of 20nm particles was injected, it was noticed that the 
surface pressure decreased after reaching a maximum (from Figure 4.7). This 
lowering of surface pressure was not observed for the larger particles and could be 
due to desorption of the penetrated particles from the lipid monolayer. Abel-Fattah 
and El-Genk stated that the sorption of colloidal particles onto the air-water 
interface is irreversible [80]. This is because the change in the total system energy, 
∆E, is always negative for both hydrophobic and hydrophilic particles. When there 
is no change in total system energy, there will be no capillary trapping and the 
adsorbed particles might desorb from the air-water interface. ∆E is defined as  
∆E = -πr2γ (cos ω - 1) 2  (4.8) 
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In the equation, γ refers to the surface tension of the colloidal solution. Since Π is 
given by the difference between the surface tension of water (γw) and surface 
tension of a monolayer (γm), by replacing γ with the term (γw - Π), we can use this 
equation to approximate the energy change in the system for the penetration of 
particles through lipid monolayers i.e. 
(∆E) Penetration = -πr2 (γw - Π)(cos ω - 1) 2      (4.9) 
where ω is the wetting contact angle of a particle. 
From Eq. 4.9, we can see that the change in total system energy caused by the 
penetration of a 200nm particle is 100 times higher than a 20nm particle. Judging 
from this, the probability of the penetrated 20nm particles desorbing from the lipid 
monolayer is much higher compared to the larger particles and hence result in the 
lowering of surface pressure observed. On the other hand, as (∆E) penetration is also 
equivalent to the energy required for the particle to penetrate the lipid monolayer, 
it shows that it is more favourable for smaller particles to penetrate, as less energy 
is required for the process. This agrees well with our results. 
 
Interestingly, desorption was only observed when high volume of particles were 
injected. A possible reason for this could be due to higher frequency of collisions 
occurring between the penetrating particles and those penetrated, causing them to 
be “knocked” out of the monolayer. Another possibility could be that the rapid, 
large amount of penetration destabilised the monolayer system, hence 
rearrangement of the various species at the interface occurred and caused some 
loss of materials into the subphase. This might also reflect that there exist a certain 
of degree of saturation imposed by the lipid monolayer for particles penetration. 
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From the opposing trend exhibited by both the mesoscopic and 20nm particles (as 
shown in Figure 4.5 and Figure 4.7), we hypothesised that there could be a critical 
size between 20nm to 200nm at which the particle behaviour would start to 
deviate from that of molecular species. This part of work is still being studied in 
our laboratory. 
 
The uptake of particles by cell occurs via endocytosis, which is an energy 
dependent process initiated by the interaction of the particle and the cell 
membranes (specifically the adsorption of the particles on the membranes) [6]. 
Based on our observations, we postulated the following possible implications: 
1. Uptake of the large particles is not favourable as more energy required for 
the process. 
2. The large increase in surface pressure could be correlated to the large 
increase in the lateral pressure in biological membranes, and this could be 
unfavourable for endocytosis to occur. 
3. Though the interaction of the smaller particles with the membranes could 
be sufficient to initiate the endocytotic process, their possible desorption 
could render the process ineffective. 
Hence, from these, our results appear to agree with what Florence and Hussain 
had suggested i.e. an optimal size is required for the occurrence of endocytosis 
[7].  
 
4.1.4  Influence of initial surface pressure on penetration 
 To further understand the interactions between the particles and the lipid 
monolayer, penetration experiments based on same injected volume of 500nm 
                                                                                                                   58   
Results and Discussions 
 
particles at different initial surface pressures of the DPPC monolayers were 
carried out. For this investigation, we used particles of only one size so that we 
could directly attribute the increase in surface pressure to the insertion of the 
particles. 
 
4.1.3.3 Initial surface pressures ranging from 30 to 35mN/m 
It had been observed that the insertion of various amphiphiles into lipid 
monolayers in this range of surface pressure resembled that for bilayers [19], 
thereby mimicking the compressed state of cell membranes. As this implied that 
the results obtained could possibly be closely analogous to interaction of the 
particles with biological membranes, more emphasis was placed on this pressure 
range. When the initial pressures were increased beyond 30mN/m, we observed 
that the penetrating effect of the particles exhibited a decreasing trend i.e. less 
penetration occurred at higher initial surface pressure. This is because as the 
monolayer is increasingly compressed, the intermolecular distance between the 
lipid molecules gets closer and thus cohesive forces between them become more 
pronounced. This cohesion creates a form of energy barrier to penetrating species 
from the subphase [16] and thereby accounts for the observed trend.  
 
In this range of surface pressure, it was also observed that the rise in the surface 
pressure was controlled and gradual (see Figure 4.8). This is because the 
monolayer now exists in the liquid-condensed (LC) phase, where the aliphatic 
chains of the lipid molecules are mostly in an all-trans-configuration [81] and are 
more closely packed (see Figure 4.9). This creates a rigid environment that gives 
rise to a high-energy barrier, hence reducing the ease of the particle penetration. 
                                                                                                                   59   













30 31 32 33 34 35








































































Figure 4.8 a) Penetration profiles of 500nm particles b) Final increase in surface pressure at 
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Figure 4.9  Π -A isotherm of DPPC at 37°C. 
 
4.1.3.4 Initial surface pressures less than 30mN/m 
 We further extended the penetration studies to lower initial surface pressures in 
order to observe how the interaction could be influenced by the different states of 
the lipid monolayer. When the initial surface pressures were higher than 20mN/m, 
the penetrating behaviour of the particles through the DPPC monolayer appeared 
to be rather erratic. As the penetration profiles are highly irregular, the penetration 
behaviour presented in  
Figure 4.10 is in the form of the final increase in Π with respect to initial Π for 
easier understanding.  In the range of surface pressure form 20mN/m to 30mN/m, 
the DPPC monolayer undergoes the liquid-expanded (LE) /liquid-condensed (LC) 
transition. It has been postulated that during this transition 3 phases i.e. the solid-
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condensed, liquid-expanded and liquid-condensed coexist, and form certain 
defects in the molecular packing that enhances the penetration of the components 
from the subphase [82]. These defects are suggested to be due to the fluctuation of 
the surface density caused by the mismatched organization of the polar head 
groups and the aliphatic chains of the lipid molecules [82], and could be 
responsible for the irregularities observed in the change in surface pressure caused 
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Figure 4.10 Final increase in surface pressure at initial surface pressures from 20mN/m to 
30mN/m. 
 
Other than at 25mN/m, there is no clear observation that particle penetration was 
enhanced during this LE/LC transition (see Figure 4.9). However, it is evident 
from the results obtained that the state of the lipid monolayer to a significant 
extent influences its interactions with the nanoparticles. 
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When the lipid monolayer was compressed to surface pressures lower than 
20mN/m, the penetration behaviour of particles exhibited similar trend as that 
observed when the lipid monolayer was in the LC state. However, the penetration 
profiles obtained indicated that the increase in surface pressure was more rapid 
and less controlled than those obtained at 30mN/m and beyond (see Figure 4.11). 
This could be due to the low-density state of the lipid monolayer. Between 10 to 
20mN/m, the DPPC monolayer existed in the fluid liquid-expanded phase (see 
Figure 4.9) where the aliphatic chains of the lipid molecules are more disordered 
due to their gauche configurations [81,82], thus creating a sparsely packed 
arrangement. This arrangement facilitates the penetration of the particles; hence a 
sharp increase in surface pressure within a short time can be observed. 
 
The results show that particle-lipid monolayer interaction is more favourable 
when the lipid monolayer is more fluidised. This observation may serve as a 
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Figure 4.11 a) Penetration profiles of 500nm particles b) Final increase in surface pressure 
from 10mN/m to 20mN/m. 
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4.2 Effect of surface coatings 
4.2.1 XPS Analysis 
 X-ray photoelectron spectroscopy (XPS) was employed to analyse the surface 
chemical composition of the various particles to ascertain that the surfactants had 
been coated onto their surfaces. The analysis of the C1s region of uncoated 
polystyrene particles (see Figure 4.12a) revealed three peaks corresponding to the 
methyl group (C-C/C-H at 285 eV), the hydroxyl group (C-OH/C-O-R at 286.36 
eV) and the carboxyl groups (O-C=O at 289.20 eV). The presence of the 
oxygenated functional groups indicates that surface oxidation had occurred on the 
polystyrene particles’ surfaces, possibly during handling or the particle fabrication 
process. This is a common phenomenon as polystyrene (PS) has been shown to 
undergo photo-oxidation in air [83]. We also observed the absence of PS 
characteristic aromatic shake-up [84], implying that it had been significantly 
reduced due to oxidation and this appeared to be a trait of oxidised PS [85]. 
 
The XPS spectra of pure TPGS, pure PVA and the respective coated particles also 
consist solely of the methyl group, the hydroxyl group and the carboxyl groups. 
The XPS spectra of the uncoated and coated particles are shown in Figure 4.12 
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Figure 4.12 XPS spectra of a) Uncoated PS particles, b) TPGS-coated particles and c) PVA-
coated particles. 
                                                                                                                   66   
Results and Discussions 
 























Pure TPGS 84.77 13.73 1.50 
TPGS-coated 
particles 
84.33 12.32 3.35 
Pure PVA 48.91 42.55 8.54 
PVA-coated 
particles 







From Table 4.1, we can see that the envelope ratios of the TPGS-coated and PVA-
coated particles are close to that of pure TPGS and PVA. This indicates that the 
particles have been successfully coated with the stabilizers remain anchored on 
their surfaces. 
 
4.2.2 Analysis of Π–A isotherms 
The surface pressure (Π)–area (A) isotherms of the various particulate monolayers 
at the air-water interface had the typical isotherm profile, exhibiting the trend of 
increasing Π as area was reduced (see Figure 4.13).  
 
For all the three sizes, i.e. 200nm, 500nm, and 800nm, it was observed that the 
surface pressure at a given area was higher for the uncoated particles, followed by 
the PVA-coated particles and lastly TPGS-coated particles. This implied that the 
inter-particle forces varied with the type of materials, as the measured surface 
pressure is a function of interfacial forces. 
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Figure 4.13  Π-A isotherms of coated and uncoated particles of size a) 200nm, b) 500nm and 
c) 800nm. 
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4.2.3 Interaction between particles at the air-water interface 
The Π-A isotherms of the particulate monolayers served as a basis to evaluate the 
strength of inter-particle forces using the Clint and Taylor method (see Section 
4.2.1) 
 
It was found that both TPGS and PVA coated particles exhibited a characteristic 
similar to those that were uncoated, i.e. the strength of the inter-particle forces 
increased with particle size (Figure 4.14). This indicates that the effect of particle 
size is predominant over the type of coating used. For more in-depth studies, we 
focused mainly on particles of one size i.e. 500nm, hence the following 
discussions (including the penetration studies) would be based on coated and 
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Figure 4.14 Force vs Spacing between particle centers curves for various particles of size a) 
200nm, b) 500nm and c) 800nm. 
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To understand the nature of the forces existing between the particles, we applied 
the van der Waals equation of state for surface monolayers to our data to evaluate 
the van der Waals constant, α (see Section 4.2.2). α is an indication of lateral 
interactions within the monolayer. The negative values we obtained  (see Figure 
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Figure 4.15 α values for coated and uncoated 500nm particles as a function of S. 
 
It was observed that the repulsive forces between the coated particles were weaker 
than the uncoated ones (see Figure 4.14 and Figure 4.15). Prieve and Bevan 
studied the effect of adsorbed Pluronic polymer on polystyrene particles and found 
that at the same separation, the van der Waals attraction existing between coated 
particles was stronger compared to the uncoated ones [86]. Since the TPGS and 
PVA coated particles also exhibited this similar behaviour, it could be possible 
that such behaviour is common for polymer-coated surfaces. Prieve and Bevan 
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had also noted that at close contact, the attraction between the coated particles was 
weaker than the uncoated particles. The attraction was weakened due to the 
repulsion that developed because of the unfavourable free energy arising from the 
compression of the adsorbed polymer chains against the surface [87]. This 
constitutes the commonly known steric stabilization. 
 
Another observation made was that between the two types of coated particles, the 
PVA coated ones exhibited stronger inter-particle repulsion compared to the 
TPGS coated ones. An insight to the chemical composition of the two polymers 
could probably offer an explanation to the observation made. Commercially 
available PVA is often partially hydrolysed, as the 100% hydrolysed form is not 
an effective stabilizer for aqueous systems [34]. This is because amphipathic 
copolymers will be more effective as they consist of one part that is compatible 
with the dispersed phase (the anchoring moiety) and another part soluble in the 
dispersion medium (the stabilizing moiety) [34]. In PVA, the unhydrolysed vinyl 
acetate group functions as the anchoring moiety, while the more hydrophilic vinyl 
alcohol group is the stabilizing moiety, and therefore PVA exhibits surfactant 
properties.  
 
For TPGS, the hydrophobic tocopheryl succinate serves as the anchoring moiety 
while the hydrophilic PEG1000 assumes the role for stabilization in an aqueous 
dispersion. The PVA used in the experiments was 87-90% hydrolysed, indicating 
that the stabilizing moiety made up approximately 87-90% of the PVA molecule. 
On the other hand, the PEG 1000 group in the TPGS makes up approximately 
two-third of the molecule. In comparison, more hydroxyl groups from a PVA 
                                                                                                                   72   
Results and Discussions 
 
molecule can be solvated than the ether linkages present in a TPGS molecule. 
Therefore, the greater repulsion between PVA coated particles could be attributed 
to the larger fraction of the stabilizing moiety and this implied that PVA offers 
better stabilisation than TPGS for colloidal systems. 
 
4.2.4 Penetration of the various particles 
For all initial Π, we found that the general trend of the final increase in Π caused 
by the penetration of the various particles was in the following order: Uncoated > 
TPGS coated > PVA coated. This is exemplified by Figure 4.16, which shows the 
penetration profile of the particles when the lipid monolayer was compressed to 
25mN/m. Since PS is a hydrophobic material, TPGS is amphipathic and PVA is 
hydrophilic, this indicates that hydrophobic materials interact favourably with the 











































Figure 4.16 Penetration profile of the various particles at initial Π = 25mN/m 
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PS particles are commonly used to study particulate uptake by cells and have 
shown to be well absorbed by the Peyer’s patches in the intestines [87,88], 
possibly due to their hydrophobicity. On the other hand, Sahoo et al found that 
despite smaller particles were formed when higher amount of PVA was used in 
the formulation, the cellular uptake of the particles was lower compared to those 
that were fabricated with less PVA and were larger in size [9]. These summed up 
that surface hydrophobicity is an important factor that affects cellular uptake, and 
the reason could be due to the formation of hydrophobic interactions between the 
particles and the cell membrane. A paradoxical situation hence arises since good 
cellular uptake may mean higher chances of the particles being phagocytosed by 
the mononuclear phagocyte system, thereby reducing the circulation period of the 
nanoparticles.  Apparently, the extent of engulfment is greater for particles that are 
more hydrophobic than the phagocytic cell compared to those that are more 
hydrophilic [89]. It is thus important, for nanoparticulate drug delivery systems 
that there must be an optimal balance between hydrophilicity and hydrophobicity 
on the particle surfaces and this could be achieved via surface modifications. 
 
TPGS has been shown to be an effective drug enhancer. Sokol et al reported that 
the absorption of cyclosporin, a hydrophobic drug, was enhanced when it was 
administered with TPGS [37]. Although there have yet been any cellular uptake 
reports on TPGS coated particles, we could postulate from our results that it could 
perform better than PVA due to its amphipathic characteristics. This is further 
investigated with cell-line experiments currently done in our laboratory. 
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From another perspective, we can also attribute the unfavourable interaction 
between hydrophilic materials and the lipid monolayer to short-range repulsive 
solvation forces.  Such forces arise between surfaces having water molecules 
bound to their hydrophilic groups [87]. At the air-water interface, the lipid 
molecules are oriented with the hydrophilic head-groups in the water phase and 
the hydrophobic tails extending into the air. As the phosphate head-group of 
DPPC can be hydrated, solvation forces will develop when hydrated penetrating 
species approach the monolayer. The strength of the solvation forces depends on 
the amount of energy required to disrupt the ordered water structure and to 
dehydrate the surfaces as they approach [87]. This implies that the larger fraction 
of hydrophilic groups present on the penetrating species, the greater the repulsion 
they will experience upon approaching the lipid monolayer. As mentioned earlier, 
a PVA molecule has more hydrophilic groups than TPGS, thus its interaction with 
the monolayer will be more repulsive in nature. 
 
The results obtained further reinforced the fact that the surface properties of the 
nanoparticles are important in determining their cellular uptake. In addition, the 
uptake of hydrophobic particles has been observed to be higher [6] and our results 
suggest that this could be due to favourable, attractive interaction between the 
nanoparticles and the lipids on the outer leaflet of the cell membranes. 
 
4.2.5 Relation between penetration and initial surface pressure 
 When a lipid monolayer is compressed, the intermolecular distance between the 
lipid molecules decreases and thus cohesive forces between them become more 
pronounced, exerting a form of energy barrier to penetrating species from the 
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subphase [16]. Consequently, if the monolayer is compressed to a high initial 
surface pressure, the ease of penetration will be lower. 
 
As mentioned previously, the significance of performing the experiments at 
surface pressures higher than 30mN/m was to closely mimic the compressed state 
of biological membranes in order to obtain a more realistic model. It was observed 
that when the DPPC monolayer was compressed to beyond 30mN/m, a distinct 
decreasing trend in penetration with respect to surface pressure was observed (see 
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Figure 4.17 Final increase in surface pressure for the various particles at monolayer initial 
surface pressure 30-33mN/m. 
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The penetrating effect (for all particles regardless of the type of coating) was less 
pronounced at the higher initial surface pressure and this could be attributed to the 
state of the monolayer. Beyond 30mN/m, the DPPC monolayer existed in the 
liquid-condensed state where the lipid molecules were more closely packed, in an 
all-trans-configuration (Figure 4.9). A more rigid environment was produced as 
the monolayer was increasingly compressed and this contributed to the reduced 
ease of penetration. 
 
To further verify investigate the effect of the different compressed states of the 
lipid monolayer, the penetration work is extended to the range of 20mN/m to 
30mN/m. Again, an irregular behaviour was observed (similar to that observed in 
Section 4.1.3.4) and the type of coating on the particles appeared to have lesser 
influence on the penetration behaviour compared to the state of the lipid 
monolayer (see Figure 4.18). However, it was observed that the penetration effect 
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Figure 4.18 Final increase in surface pressure for the various particles at monolayer initial 
surface pressure 20-30mN/m. 
 
The irregular trend can again be attributed to the liquid-expanded /liquid-
condensed transitional state of the lipid monolayer.  As a result, though the 
penetration profiles obtained exhibited contradictory trends in this range of 
surface pressures but they gave evidence that the state of the monolayer was 
critical for the insertion of any species into the monolayer and is an issue that 
could be exploited to enhance cellular uptake of particles. 
. 




Chapter 5 : Conclusions 
 
 
The formation of particulate monolayers at the air-water interface allows us to 
obtain data that is useful for estimating the strength of the inter-particles forces 
present as well as for investigating the nature of these forces. Our results agree 
with the notion that forces within the 2-dimensional monolayer are analogous to 
those in 3-dimensional suspensions. We have found that the strength of the inter-
particle forces increases with particle size and the net overall effect of these forces 
is repulsive. This repulsion increases to a maximum and then weakens as the 
particles are compressed closer to each other.  
 
The interaction between nanoparticles and the lipid monolayer is expressed in the 
form of penetration profiles. These profiles are strongly affected by the size of the 
penetrating particles. The interpretation of the profiles for particles in mesoscopic 
size range (200, 500 and 800nm particles) is not straightforward, i.e. the increase 
in surface pressure cannot be solely attributed to the insertion of the particles. 
Inter-particle interactions play an important role and must not be overlooked for 
this case. On the other hand, because of its significantly smaller size, the 20nm 
particles exhibit behaviour close to molecular species and diffusivity seems to be a 
dominant factor affecting the penetration profile for 20nm particles. A lowering of 
surface pressure has been observed at when a large volume of 20nm particles was 
injected but this is not observed for the mesoscopic particles. This phenomenon is 
possibly caused by desorption of particles from the lipid monolayer and could be 




attributable to the small change in total system energy, as well as loss of materials 
due to rearrangement within the monolayer. 
 
To study the effect of surface coatings, the particles were coated with PVA and 
TPGS. PVA is a commonly used surfactant for synthesizing nanoparticulate drug 
delivery systems and recently TPGS has exhibited its potential as an effective 
stabilizing agent. The inter-particle forces existing between the various particles 
were found to be repulsive and got stronger as the particle size increases 
regardless of the type of coating. However, it was observed that the repulsion 
between the PVA and TPGS coated particles was weaker than that between the 
uncoated ones. In comparison, the PVA coated particles exhibit greater inter-
particle repulsion than those coated with TPGS and this could be due to the larger 
stabilizing moiety of the PVA molecule. 
 
The penetration results suggest that the lipid monolayer interacts preferentially 
with hydrophobic materials, hence agreeing with the notion that surface 
hydrophobicity is an important factor influencing cellular uptake of particulates. 
Although there have yet been any cellular uptake publications based on TPGS 
coated particles, it is possible that it would perform better than PVA due to its 
amphipathic characteristics.  
 
Finally, it was found that the state of the lipid monolayer greatly influences its 
interactions with the nanoparticles, regardless of their size or type of coating 
present. Erratic trends have been observed when the monolayer exists in the 
LE/LC transitional phase. In LE or LC phase, trends are more predictable, 




showing that the ease of particle penetration has an inverse relationship with the 
monolayer’s initial surface pressure. 
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Figure A.1 Surface pressure vs trough area for a) uncoated particles of different sizes, b) 
coated and uncoated 500nm particles. 



























































Figure A.2 Fitted curves for data from Figure 4.8a 
 
Equations of various fitted curves: 
 
For data at 30mN/m, 
y = -2E-20x6 + 2E-16x5 - 1E-12x4 + 3E-09x3 - 3E-06x2 + 0.0022x 
R2 = 0.9951 
 
For data at 31mN/m, 
y = 2E-21x6 + 3E-18x5 - 1E-13x4 + 7E-10x3 - 1E-06x2 + 0.0013x 
R2 = 0.99 
 
For data at 33mN/m, 
y = -2E-20x6 + 2E-16x5 - 8E-13x4 + 2E-09x3 - 1E-06x2 + 0.0009x 
R2 = 0.9907 
 
For data at 35mN/m, 
y = -1E-20x6 + 1E-16x5 - 6E-13x4 + 1E-09x3 - 1E-06x2 + 0.001x 
R2 = 0.9848 
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